World Tech News Turkmenistan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Tech News Turkmenistan.

Press releases published on October 30, 2026

6 hours ago

Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

6 hours ago

Syndax Announces Participation in November Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Indeterminate GlobeNewswire

6 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

Indeterminate GlobeNewswire

6 hours ago

Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA

Indeterminate GlobeNewswire

6 hours ago

Agility Robotics and Churchill Capital Corp XI Announce Expected Gross Capital Raise of Approximately $465 Million and Anticipated Closing of Business Combination

Indeterminate GlobeNewswire

6 hours ago

Aurora Mobile’s Modellix.ai Brings Unified AI Model Access to ComfyUI Creative Workflows

Indeterminate GlobeNewswire

6 hours ago

Regeneron Reports Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

6 hours ago

LyondellBasell agrees to sell former refinery site in Houston

Indeterminate GlobeNewswire

7 hours ago

CT UAV Determined Not to Be Outdone by Germany or Japan

Indeterminate GlobeNewswire

7 hours ago

Repligen Announces $1 Billion Private Convertible Senior Notes Transaction

Indeterminate GlobeNewswire

7 hours ago

Emdoor Information Expands Rugged AI PC Portfolio for Intelligent Edge Applications

Indeterminate GlobeNewswire

8 hours ago

Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation

Indeterminate GlobeNewswire

8 hours ago

Tangram gibt bekannt, dass der erste Teilnehmer im Rahmen der Phase-I-Studie mit TGM-148, einem neuartigen RNAi-Prüfpräparat zur Behandlung von Blutungsstörungen, die erste Dosis erhalten hat

Indeterminate GlobeNewswire

8 hours ago

Tangram annonce l’administration du TGM-148 au premier participant de l’essai de phase 1 évaluant le TGM-148, un nouveau médicament expérimental à ARNi contre les troubles hémorragiques

Indeterminate GlobeNewswire

9 hours ago

Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution

Indeterminate GlobeNewswire

10 hours ago

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026

Indeterminate GlobeNewswire

10 hours ago

Nicox Reports First Half 2026 Financial Results

Indeterminate GlobeNewswire

10 hours ago

Nicox publie les résultats financiers du premier semestre 2026

Indeterminate GlobeNewswire

10 hours ago

Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded

Indeterminate GlobeNewswire